Results 171 to 180 of about 114,734 (260)

Bladder mass following bone marrow transplant for sickle cell disease: A diagnostic dilemma. [PDF]

Clin Hematol Int
Adelabu Y, Fakile UO, Oladimeji WQ, Oseni K, Ogunjimi MA, Bamigboye TG, Aziken-John BN, Enegbuma A, Olayiwola Z, Kalejaiye O, Adeyemo TA, Ogbenna A, Wilkerson K, Temiye E, Akinsete AM, Kassim AA.   +15 more
europepmc   +1 more source

Effects of tempol on renal medullary tissue hypoxia in an ovine model of Gram‐negative septic acute kidney injury

Experimental Physiology, EarlyView.
Abstract Renal arterial infusion of tempol (RAT) at the onset of Gram‐negative sepsis can prevent sepsis‐induced medullary tissue hypoxia and acute kidney injury (AKI). However, it is not known whether treatment with tempol at a clinically relevant time point of sepsis is similarly effective. Thus, we examined whether tempol can reverse renal medullary
Rachel Peiris, Anton Trask‐Marino, Alemayehu Jufar, Ashenafi H. Betrie, Adam Southon, Sally G. Hood, Rinaldo Bellomo, Abraham H. Hulst, Clive N. May, Connie P. C. Ow, Yugeesh R. Lankadeva   +10 more
wiley   +1 more source

Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma. [PDF]

World J Exp Med
Wishahi M.
europepmc   +1 more source

Coordinated regulation of PIEZO2 by alternative splicing, post‐translational modification, membrane trafficking and protein partners

The Journal of Physiology, EarlyView.
Abstract figure legend Regulatory mechanisms such as alternative splicing, post‐translational modification, membrane trafficking, and protein interactions control channel gating, membrane abundance, and overall activity of PIEZO2. Proper regulation supports PIEZO2‐dependent proprioceptive, somatosensory, nociceptive, pruriceptive and interoceptive ...
Eunice I. Oribamise, Qinglu Li, Mary G. Garry   +2 more
wiley   +1 more source

Case Report of Urethral Stenting in a Dog with Multifactorial Lower Urinary Tract Obstruction Associated with Suspected Transitional Cell Carcinoma and Severe Cystolithiasis. [PDF]

Vet Sci
Lee SH, Seo JH, Ryu Y, Cho JH.
europepmc   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Papillary urothelial tumor of low malignant potential in a pediatric patient: case associated with Poland syndrome. [PDF]

Urol Case Rep
Arias K, Ceballos ML, Ordoñez JL, Medina EA, Duque M.   +4 more
europepmc   +1 more source

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12 ‐Related Developmental Disorders

American Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1619-1650, July 2026.
ABSTRACT The rare X‐linked female‐restricted Hardikar syndrome (HDKR, OMIM # 301068) is characterized by multiple congenital anomalies including orofacial clefts, gastrointestinal, genitourinary, and cardiac anomalies, but cognitive and neurobehavioral development is rarely impaired.
Tinne Warmoeskerken, Miel Theunis, Kris Van den Bogaert, Koenraad Devriendt, Jeroen Breckpot   +4 more
wiley   +1 more source

Recurrent pediatric vesical lymphangioma: The first case report of early relapse after transurethral resection and successful endoscopic management. [PDF]

Urol Case Rep
Bourimi C, Tariqi R, Mesbahi S, Gounni MY, Kibanzala J, Fekkar A, Rais M, Boualaoui I, Ibrahimi A, Nouini Y.   +9 more
europepmc   +1 more source